Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function

被引:94
作者
Levin, Edward D. [1 ]
Rezvani, Amir H. [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA
关键词
nicotine; clozapine; haloperidol; risperidone; memory; attention; schizophrenia;
D O I
10.1016/j.bcp.2007.07.019
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
People with schizophrenia often have substantial cognitive impairments, which may be related to nicotinic receptor deficits, (alpha 7 and alpha 4 beta 2), documented in the brains of people with schizophrenia. The large majority of people with schizophrenia smoke cigarettes. Thus, nicotinic interactions with antipsychotic drugs are widespread. Complementary co-therapies of novel nicotinic ligands are being developed to add to antipsychotic therapy to treat the cognitive impairment of schizophrenia. Thus, it is critical to understand the interaction between nicotinic treatments and antipsychotic drugs. Nicotinic interactions with antipsychotic drugs, are complex since both nicotine and antipsychotics have complex actions. Nicotine stimulates and desensitizes nicotinic receptors of various subtypes and potentiates the release of different neurotransmitters. Antipsychotics also act on a verity of receptor systems. For example, clozapine acts as an antagonist at a variety of neurotransmitter receptors such as those for dopamine, serotonin, norepinepherine and histamine. In a series of studies, we have found that in normally functioning rats, moderate doses of clozapine impair working memory and that clozapine blocks nicotine-induced memory and attentional improvement. Clozapine and nicotine can attenuate each other's beneficial effects in reversing the memory impairment caused by the psychototmimetic drug dizocilpine. A key to the clozapine-induced attenuation of nicotine-induced cognitive improvement appears to be its 5HT(2) antagonist properties. The selective 5HT(2) antagonist ketanserin has a similar action of blocking nicotine-induced memory and attentional improvements. It is important to consider the interactions between nicotinic and antipsychotic drugs to develop the most efficacious treatment for cognitive improvement in people with schizophrenia. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1182 / 1191
页数:10
相关论文
共 108 条
[1]   Group treatment for smoking cessation among persons with schizophrenia [J].
Addington, J .
PSYCHIATRIC SERVICES, 1998, 49 (07) :925-928
[2]   Nicotine interactions with haloperidol, clozapine and risperidone and working memory function in rats [J].
Addy, N ;
Levin, ED .
NEUROPSYCHOPHARMACOLOGY, 2002, 27 (04) :534-541
[3]   Schizophrenia, sensory gating, and nicotinic receptors [J].
Adler, LE ;
Olincy, A ;
Waldo, M ;
Harris, JG ;
Griffith, J ;
Stevens, K ;
Flach, K ;
Nagamoto, H ;
Bickford, P ;
Leonard, S ;
Freedman, R .
SCHIZOPHRENIA BULLETIN, 1998, 24 (02) :189-202
[4]  
ADLER LE, 1993, AM J PSYCHIAT, V150, P1856
[5]   Improved P50 auditory gating with ondansetron in medicated schizophrenia patients [J].
Adler, LE ;
Cawthra, EM ;
Donovan, KA ;
Harris, JG ;
Nagamoto, HT ;
Olincy, A ;
Waldo, MC .
AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (02) :386-U5
[6]   Nicotine dependence and symptoms in schizophrenia - Naturalistic study of complex interactions [J].
Aguilar, MC ;
Gurpegui, M ;
Diaz, FJ ;
De Leon, J .
BRITISH JOURNAL OF PSYCHIATRY, 2005, 186 :215-221
[7]   IMPROVED LEARNING AND MEMORY IN AGED RATS WITH CHRONIC ADMINISTRATION OF THE NICOTINIC RECEPTOR AGONIST GTS-21 [J].
ARENDASH, GW ;
SENGSTOCK, GJ ;
SANBERG, PR ;
KEM, WR .
BRAIN RESEARCH, 1995, 674 (02) :252-259
[8]   Effects of nicotine on leading saccades during smooth pursuit eye movements in smokers and nonsmokers with schizophrenia [J].
Avila, MT ;
Sherr, JD ;
Hong, E ;
Myers, CS ;
Thaker, GK .
NEUROPSYCHOPHARMACOLOGY, 2003, 28 (12) :2184-2191
[9]   Reversal of isolation-rearing-induced PPI deficits by an α7 nicotinic receptor agonist [J].
Cilia, J ;
Cluderay, JE ;
Robbins, MJ ;
Reavill, C ;
Southam, E ;
Kew, JNC ;
Jones, DNC .
PSYCHOPHARMACOLOGY, 2005, 182 (02) :214-219
[10]   Nicotine dependence in schizophrenia: Clinical phenomena and laboratory findings [J].
Dalack, GW ;
Healy, DJ ;
Meador-Woodruff, JH .
AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (11) :1490-1501